287 related articles for article (PubMed ID: 16953816)
1. Evaluation of RANK/RANKL/OPG gene polymorphisms in aggressive periodontitis.
Soedarsono N; Rabello D; Kamei H; Fuma D; Ishihara Y; Suzuki M; Noguchi T; Sakaki Y; Yamaguchi A; Kojima T
J Periodontal Res; 2006 Oct; 41(5):397-404. PubMed ID: 16953816
[TBL] [Abstract][Full Text] [Related]
2. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations in the genes encoding receptor activator nuclear factor κ B (RANK), receptor activator nuclear factor κ B ligand (RANKL) and osteoprotegerin (OPG) in patients with psoriasis and psoriatic arthritis: a case-control study.
Assmann G; Pfoehler C; Simon P; Pfreundschuh M; Tilgen W; Wieczorek S
J Dermatol; 2011 Jun; 38(6):519-23. PubMed ID: 21352301
[TBL] [Abstract][Full Text] [Related]
5. [Genomic approaches to bone and joint diseases. Mutations of RANK, OPG and RANKL genes found in humans].
Kobayashi Y; Takahashi N
Clin Calcium; 2008 Feb; 18(2):202-9. PubMed ID: 18245890
[TBL] [Abstract][Full Text] [Related]
6. Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis.
Lu HK; Chen YL; Chang HC; Li CL; Kuo MY
J Periodontal Res; 2006 Aug; 41(4):354-60. PubMed ID: 16827732
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis.
Baioni CS; de Souza CM; Ribeiro Braosi AP; Luczyszyn SM; Dias da Silva MA; Ignácio SA; Naval Machado MA; Benato Martins WD; Riella MC; Pecoits-Filho R; Trevilatto PC
J Periodontal Res; 2008 Oct; 43(5):578-84. PubMed ID: 18624938
[TBL] [Abstract][Full Text] [Related]
8. Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Atilla G; Hughes FJ; Belibasakis GN
J Clin Periodontol; 2007 May; 34(5):370-6. PubMed ID: 17355365
[TBL] [Abstract][Full Text] [Related]
9. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
10. [Osteoprotegerin mRNA/receptor activator of NF-kappaB ligand mRNA expressions in bone tissues of glucocorticoid-induced osteonecrosis of the femoral head].
Wang J; Wang K; Shi Z; Zhang M
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Oct; 22(10):1161-4. PubMed ID: 18979868
[TBL] [Abstract][Full Text] [Related]
11. Biology of RANK, RANKL, and osteoprotegerin.
Boyce BF; Xing L
Arthritis Res Ther; 2007; 9 Suppl 1(Suppl 1):S1. PubMed ID: 17634140
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases.
Bostanci N; Ilgenli T; Emingil G; Afacan B; Han B; Töz H; Berdeli A; Atilla G; McKay IJ; Hughes FJ; Belibasakis GN
J Periodontal Res; 2007 Aug; 42(4):287-93. PubMed ID: 17559623
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines in bone diseases. Genetic disorders of RANKL-RANK-OPG system].
Tokuyama N; Tanaka S
Clin Calcium; 2010 Oct; 20(10):1532-8. PubMed ID: 20890036
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor-kappaB ligand (RANKL) directly modulates the gene expression profile of RANK-positive Saos-2 human osteosarcoma cells.
Mori K; Berreur M; Blanchard F; Chevalier C; Guisle-Marsollier I; Masson M; Rédini F; Heymann D
Oncol Rep; 2007 Dec; 18(6):1365-71. PubMed ID: 17982618
[TBL] [Abstract][Full Text] [Related]
15. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis.
Kadkhodazadeh M; Ebadian AR; Gholami GA; Khosravi A; Tabari ZA
Arch Oral Biol; 2013 May; 58(5):530-6. PubMed ID: 23177932
[TBL] [Abstract][Full Text] [Related]
16. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
[TBL] [Abstract][Full Text] [Related]
17. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
[TBL] [Abstract][Full Text] [Related]
18. Gene-gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women.
Zupan J; Mencej-Bedrac S; Jurković-Mlakar S; Prezelj J; Marc J
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):102-6. PubMed ID: 19896533
[TBL] [Abstract][Full Text] [Related]
19. Influence of lipopolysaccharide and interleukin-6 on RANKL and OPG expression and release in human periodontal ligament cells.
Krajewski AC; Biessei J; Kunze M; Maersch S; Perabo L; Noack MJ
APMIS; 2009 Oct; 117(10):746-54. PubMed ID: 19775343
[TBL] [Abstract][Full Text] [Related]
20. Effect of smoking on serum RANKL and OPG in sex, age and clinically matched supportive-therapy periodontitis patients.
Lappin DF; Sherrabeh S; Jenkins WM; Macpherson LM
J Clin Periodontol; 2007 Apr; 34(4):271-7. PubMed ID: 17378883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
